CAR-T is the short name for Chimeric Antigen Receptor T-Cell Immunotherapy. To put it simply, CAR-T is to transform the patient’s immune T cells in vitro to make them recognize the antigens on the surface of tumor cells, and then ...
internet Forum.io Latest Articles
Microfluidic Chips: A Paradigm Shift in Systemic Research and Point-of-Care Testing
Microfluidic chips have garnered significant interest from both academic and industrial sectors since their inception. The launch of the journal “Lab on a Chip” in 2001 marked a pivotal moment, quickly establishing itself as a cornerstone publication and catalyzing further ...
From Electrophoresis to High-Throughput Screening: The Journey of Microfluidic Chips
The global market for microfluidic products reached $9.98 billion in 2019, with microfluidic devices contributing $3.48 billion of this total. A notable industry trend is the acquisition of microfluidic companies by larger corporations, signaling an era of accelerated growth ...
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics is proud to announce Plaque Reduction Assay services to support antiviral research. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive suite of Plaque ...
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics announces its new line of Norovirus VLP Antigens for in vitro diagnostics and vaccine research. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line ...
Novel Therapies Based on Small-Molecule Antibodies Hold Promise
Antibodies, the extraordinary proteins that serve as the frontline troops of the human immune system, have recently gained attention for their ability to combat tiny compounds known as haptens. Because of their small size, these elusive targets present particular difficulty ...
Immune Checkpoint Therapy and Small Molecule Drug Development Services
Cancer has long been a tough opponent in the realm of medicine, with its complicated and diversified character making effective treatment difficult. Recent advancements in immunotherapy, particularly immune checkpoint therapy, as well as the creation of small molecule medicines, have, ...
A New Potential Medication to Fight the Monkey Pox Virus
The monkeypox virus, also called MPOX virus, which is rapidly spreading throughout the world’s nations, has posed a significant risk to the health of the people, resulting in many deaths. The news reported that patients with immunodeficiency are at high ...
Potential Treatment Strategies for CNS Diseases Require More Research
For several decades, CNS diseases have caused serious burdens for individuals with these diseases in both physical and mental health. Studies show that more than 95% of CNS diseases have an unknown etiology, which presents scientists with significant obstacles on ...
Solutions Help Smooth the Development Journey of Liposome Drug Delivery
According to the latest market report about liposome and nanoparticle drug delivery, the market size and market share continue to expand in 2023 and will be expected to touch USD 8977.8 million by 2028. These data obviously prove the extensive ...